The Steady-State Comparative Bioavailability of Intramuscular Risperidone ISM and Oral Risperidone: An Open-Label, One-Sequence Study [Corrigendum]

Autor: Walling DP, Hassman HA, Anta L, Ochoa L, Ayani I, Martínez J, Gutierro I

Publikováno v: Drug Design, Development and Therapy, Vol Volume 16, Pp 1791-1792 (2022)

Walling DP, Hassman HA, Anta L, et al. Drug Des Devel Ther. 2021;15:4371–4382. Page 4378, Table 2, PK Parameter column, the text “Cave (ng/nL)” should read “Cave (ng/mL)”. Page 4379, Table 3, PK Parameter column, the text “Cave (ng/nL)”

Externí odkaz: https://doaj.org/article/72234dfaaa7a41919e747cfd6aa4e887

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Cognitive effects, pharmacokinetics, and safety of zuranolone administered alone or with alprazolam or ethanol in healthy adults in a phase 1 trial.

Autor: Dunbar J; Sage Therapeutics, Inc., Cambridge, MA, USA., Walling DP; CenExel CNS, Los Alamitos, CA, USA., Hassman HA; CenExel Hassman Research Institute, Marlton, NJ, USA., Jain R; Texas Tech University School of Medicine, Austin, TX, USA., Czysz A; Sage Therapeutics, Inc., Cambridge, MA, USA., Nandy I; Sage Therapeutics, Inc., Cambridge, MA, USA., Ona V; Sage Therapeutics, Inc., Cambridge, MA, USA., Moseley MK; Biogen, Inc., Cambridge, MA, USA., Levin S; Biogen, Inc., Cambridge, MA, USA., Maruff P; Cogstate, New Haven, CT, USA.

Publikováno v: Journal of psychopharmacology (Oxford, England) [J Psychopharmacol] 2024 Dec; Vol. 38 (12), pp. 1122-1136. Date of Electronic Publication: 2024 Oct 11.